Simvastatin reduced triglycerides but had no effect on palmitate in type 2 diabetes

	Tweet

Simvastatin reduced serum triglycerides but had no effect on plasma palmitate concentrations in patients with type 2 diabetes mellitus.

“Statins improve all major lipid fractions, reduce coronary heart disease risk, and may have a minor effect on glucose tolerance. A reduction in free fatty acid flux and concentrations could be partly responsible for these effects,” scientists writing in the journal Metabolism - Clinical and Experimental report.

W.L. Isley and colleagues at the Mayo Clinic in Rochester “measured nocturnal and postprandial plasma palmitate concentrations and rate of appearance (R[a]) on 2 occasions in 12 obese dyslipidemic subjects with type 2 diabetes mellitus, using a single-blind, crossover format (placebo followed by simvastatin, 80 mg/d), and also on 1 occasion in 6 untreated control subjects.”

The investigators found, “The diabetic subjects had increased average nocturnal (127 (plusminus)13 vs 80(plusminus)10 mcmol/L, p<0.05) and 2-hour postprandial (49(plusminus)6 vs 17(plusminus)2 mcmol/L, p<0.001) palmitate concentrations, as well as increased nocturnal (31.6(plusminus)3.7 vs 19.5(plusminus)3.7 mmol/m(2) over 9 hours, p<0.05) and postprandial (11.5(plusminus)3.7 vs 5.5(plusminus)3.7 mmol/m(2) over 4 hours, p<0.005) integrated palmitate R[a] compared to normal controls.”

The authors concluded, “High-dose simvastatin reduced serum triglycerides by 35% but had no effect on plasma palmitate concentrations or R[a].These results suggest that the triglyceride-lowering effect of Statins is not mediated through an effect on FFA metabolism.”

Isley and colleagues published their study in Metabolism - Clinical and Experimental (The effect of high-dose simvastatin on free fatty acid metabolism in patients with type 2 diabetes mellitus. Metabolism, 2006;55(6):758-762).

Additional information can be obtained by contacting W.L. Isley, Mayo Clinic, Division Endocrinol Nutrition & Metab, Endocrine Research Unit, Rochester, MN 55905, USA.

The publisher of the journal Metabolism - Clinical and Experimental can be contacted at: W B Saunders Co-Elsevier Inc., Independence Square West Curtis Center, Ste. 300, Philadelphia, PA 19106-3399, USA.

RELATED STORIES:
Phone contact with nurses linked with better outcomes for women with gestational diabetes   Death rate drops among Americans with diabetes -CDC   Correct treatment of common diabetic foot infections can reduce amputations   “Pre-diabetes,” diabetes rising among U.S. teens   Experimental bariatric surgery controls blood sugar in rats with diabetes   53 millions Americans might develop diabetes by 2025   New inflammation hormone link may pave way to study new drugs for type 2 diabetes   Diabetic retinopathy research could reduce screening costs   Liver fat gets a wake-up call that maintains blood sugar levels   Low testosterone levels could raise diabetes risk for men   Prosthetic lets diabetic get a foot up on life   Dealing with Diabetes, One Patient at a Time

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]